Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 24014 | Zelasudil | 2365193-22-0 | ≧98.0% |  |
| Zelasudil is a potent, highly selective and orally-active inhibitor that targets Rho- | ||||
| 24013 | Ziftomenib ( KO-539 ) | 2134675-36-6 | ≧98.0% | _2134675-36-6.png) |
| Ziftomenib is an oral, potent, and selective small molecule inhibitor that targets th | ||||
| 24012 | Zunsemetinib | 1640282-42-3 | ≧98.0% |  |
| Zunsemetinib is an investigational oral mitogen-activated protein kinase-activated pr | ||||
| 24011 | Zongertinib | 2728667-27-2 | ≧98.0% |  |
| Zongertinib [BI 1810631] is a human epidermal growth factor receptor 2 (HER2) inhibit | ||||
| 24010 | Zasocitinib | 2272904-53-5 | ≧98.0% |  |
| Zasocitinib is under development for the treatment of moderate to severe plaque psori | ||||
| 20657 | Zilurgisertib | 2173389-57-4 | ≧98.0% |  |
| Zilurgisertib (earlier known as INCB 00928) is an activin receptor-like kinase-2 (ALK | ||||
| 20651 | Zatolmilast | 1606974-33-7 | 98% Min. |  |
| Zatolmilast is a phosphodiesterase IV inhibitor. | ||||
| 20628 | Zagociguat | 2201048-82-8 | 98% Min. |  |
| Zagociguat is a guanylate cyclase activator. | ||||
| 20610 | Zavondemstat | 1851412-93-5 | ≧98.0% |  |
| Zavondemstat is a KDM4 inhibitor with potential as an antineoplastic agent. | ||||
| 20567 | 1Z105 | 1438280-73-9 | 98% Min. |  |
| 1Z105 is a TLR4/MD2 ligand, significantly reducing the IL-6 secretion by subsequent c | ||||
| 20524 | Zidesamtinib ( NVL-520 ) | 2739829-00-4 | ≧98.0% |  |
| Zidesamtinib ( NVL-520 ) is a novel brain-penetrant ROS1-selective tyrosine kinase in | ||||
| 20513 | ZINC40099027 (ZN27) | 1211825-25-0 | ≧98.0% |  |
| ZINC40099027 (ZN27) is a specific focal adhesion kinase (FAK) activator that promotes | ||||
| 20446 | Zagociguat | 2201048-82-8 | 98% Min. | |
| Zagociguat is a guanylate cyclase activator. | ||||
| 20416 | Z-ALA-OSU | 3401-36-3 | 98% Min. |  |
| 20318 | Zotizalkib ( TPX-0131 ) | 2648641-36-3 | ≧98.0% | _2648641-36-3.png) |
| TPX-0131 is a next-generation ALK inhibitor drug candidate currently being evaluated | ||||
| 20317 | Zipalertinib | 1661854-97-2 | 98% Min. |  |
| Zipalertinib, also known as TAS6417, CLN-081, is a Novel EGFR Inhibitor Targeting Exo | ||||
| 20301 | ZZW-115 | 801991-87-7 | 98% Min. |  |
| ZZW-115is a potent NUPR1 inhibitor. ZZW-115 induces ferroptosis in a mitochondria-dep | ||||
| 2071629 | (3Z)-5-bromo-3-[(3-bromo-4,5-dihydroxyphenyl)methylidene]-1H-indol-2-one | 486443-73-6 | 98% Min. | -5-bromo-3-[(3-bromo-4,5-dihydroxyphenyl)methylidene]-1H-indol-2-one_486443-73-6.png) |
| LC3-mHTT-IN-AN1 (Compound AN1) is amHTT-LC3linker compound, which interacts with both | ||||
| 2071513 | ZK824859 | 2254001-81-3 | 98% Min. |  |
| ZK824859 is a potent uPA inhibitor as a potential treatment for multiple sclerosis. Z | ||||
| 193281 | ZL0454 | 2229042-77-5 | >98% |  |
| ZL0454 is a potent and selective BRD4 inhibitor. ZL0454 reduces airway inflammation a | ||||
| 19352 | ZM223 | 2031177-48-5 | >98% |  |
| ZM223 is a novel non-sulfamide NEDD8 activating enzyme inhibitor that inhibits HCT116 | ||||
| 181233 | Z944 | 1199236-64-0 | >98% |  |
| Z944 is a T-type calcium channel antagonist potentially for the treatment of pain. Z9 | ||||
| 189271 | Zamicastat | 1080028-80-3 | >98% |  |
| Zamicastat is a potent and selective dopamine β-mono-oxygenase inhibitor. | ||||
| 185186 | Zardaverine | 101975-10-4 | >98% |  |
| Zardaverine is a Phosphodiesterase 3/4 inhibitor. | ||||
| 18577 | Zanubrutinib | 1691249-45-2 | >98% |  |
| Zanubrutinib, aslo known as BGB-3111, is a potent and highly selective small molecule | ||||
| 183213 | 4-(羟基甲基)苯乙酸甲酯 | 155380-11-3 | >96% | 苯乙酸甲酯_155380-11-3.png) |
| 4-(羟基甲基)苯乙酸甲酯是一种药物中间体。 | ||||
| 183212 | 4-(羟甲基)苯醋酸 | 73401-74-8 | >96% | 苯醋酸_73401-74-8.png) |
| 4-(羟甲基)苯醋酸是一种药物中间体。 | ||||
| 183211 | 4-(溴乙烷)苯乙酸 | 13737-36-5 | >96% |  |
| 4-(溴乙烷)苯乙酸是一种药物中间体。 | ||||
| 1712151 | 1-(2-乙基)-4 -(3-苯丙基)哌嗪 | 76778-22-8 | >98% |  |
| GBR-12935是一种哌嗪衍生物,是一种有效和选择性多巴胺再摄取抑制 | ||||
| 1712142 | 盐酸依替福辛 | 56776-32-0 | >98% |  |
| 盐酸依替福辛，又称HOE 36801和etafenoxine，是Hoechst在上世纪60年代开 | ||||